Arthur He
Stock Analyst at HC Wainwright & Co.
(0.79)
# 3,804
Out of 4,868 analysts
64
Total ratings
25.86%
Success rate
-22.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Reiterates: Buy | $20 | $4.65 | +330.11% | 10 | Jun 17, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $75 → $85 | $20.92 | +306.31% | 2 | Jun 2, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | n/a | $1.80 | - | 8 | May 20, 2025 | |
| ADAG Adagene | Reiterates: Buy | $8 | $1.95 | +310.26% | 10 | Apr 3, 2025 | |
| ADAP Adaptimmune Therapeutics | Maintains: Buy | $3.5 → $3 | $0.26 | +1,071.88% | 6 | Apr 1, 2025 | |
| BCAB BioAtla | Reiterates: Neutral | n/a | $0.40 | - | 8 | Mar 31, 2025 | |
| LVTX LAVA Therapeutics | Reiterates: Neutral | $1.5 | $1.34 | +11.94% | 10 | Mar 31, 2025 | |
| NKTR Nektar Therapeutics | Reiterates: Buy | $98 | $8.61 | +1,032.40% | 3 | Mar 13, 2025 | |
| HOOK HOOKIPA Pharma | Downgrades: Neutral | n/a | $1.31 | - | 7 | Jan 10, 2025 |
Solid Biosciences
Jun 17, 2025
Reiterates: Buy
Price Target: $20
Current: $4.65
Upside: +330.11%
Vera Therapeutics
Jun 2, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $20.92
Upside: +306.31%
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.80
Upside: -
Adagene
Apr 3, 2025
Reiterates: Buy
Price Target: $8
Current: $1.95
Upside: +310.26%
Adaptimmune Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $0.26
Upside: +1,071.88%
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.40
Upside: -
LAVA Therapeutics
Mar 31, 2025
Reiterates: Neutral
Price Target: $1.5
Current: $1.34
Upside: +11.94%
Nektar Therapeutics
Mar 13, 2025
Reiterates: Buy
Price Target: $98
Current: $8.61
Upside: +1,032.40%
HOOKIPA Pharma
Jan 10, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.31
Upside: -